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DObjective: The creation of consistently transmural lesions with epicardial ablation on the beating heart has rep-
resented a significant challenge for current technology. This study examined the chronic performance of the
AtriCure Coolrail device (AtriCure Inc, West Chester, Ohio), an internally cooled, bipolar radiofrequency ab-
lation device designed for off-pump epicardial ablation. The study also examined the reliability of using acute
intraoperative conduction delay to evaluate lesion integrity.
Methods: Seven swine underwent median sternotomy. The right atrial appendage and inferior vena cava were
isolated with a bipolar radiofrequency clamp. Linear ablation lines were created between these structures with
the AtriCure Coolrail. Paced activation maps were recorded with epicardial patch electrodes acutely before and
after ablation and after keeping the animals alive for 4 weeks. The conduction time across the linear ablation was
calculated from these maps. The lesions were histologically evaluated with trichrome staining.
Results: Only 76% of cross-sections of Coolrail lesions were transmural, and only 1 of 12 ablation lines was
transmural in every cross-section examined. Mapping data were available in 5 of the animals. Significant con-
duction delay was present after the creation of each line of ablation acutely; however, after 4 weeks, conduction
time returned to preablation values, demonstrating lack of transmurality.
Conclusions: The AtriCure Coolrail failed to reliably create transmural lesions. Although the Coolrail was able
to create acute conduction delay, its failure to transmurally ablate the atrial myocardium left gaps along the
length of the lesion, which resulted in neither chronic conduction block nor delay across any line of ablation.
(J Thorac Cardiovasc Surg 2012;144:859-65)The Cox-Maze procedure, introduced in 1987, was the first
successful surgical treatment of atrial fibrillation (AF). The
procedure involved creating incisions in both atria to inter-
rupt the reentrant circuits that were thought to be responsi-
ble for AF. In long-term follow-up at Barnes-Jewish
Hospital, the Cox-Maze III procedure achieved more than
90% success in curing symptomatic AF,1 although the
cut-and-sew procedure was technically difficult and time-
consuming. During the past decade, alternative energy sour-
ces have been used to replace the incisions of the Cox-Maze
III procedure. These have included radiofrequency (RF) en-
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The Journal of Thoracic and Caultrasound.2-5 Although simpler and less invasive than the
Cox-Maze III procedure, these ablation-based procedures
often still involved cardiopulmonary bypass. To develop
a less-invasive beating heart approach, devices have been
developed to perform epicardial ablation to circumvent
the need for cardiopulmonary bypass. However, despite
the introduction of a variety of energy sources and the use
of supplemental irrigation or suction, no device has yet
been able to create reliable continuous transmural lesions.6
This study had 2 specific aims. First, the chronic perfor-
mance of a novel internally cooled RF device designed for
epicardial atrial ablation, the AtriCure Coolrail (AtriCure
Inc, West Chester, Ohio), was examined. This device has
been used clinically to create linear lesions but has not un-
dergone previous chronic experimental evaluation. Second,
this experiment was designed to evaluate the reliability of
using intraoperative conduction delay and block as a means
to predict the chronic transmurality of RF lesions.
Because of the failure of previous technologies on the
beating heart, a method to predict transmurality of lesions
intraoperatively is needed to evaluate the efficacy of off-
pump ablation. Conduction delay or conduction block
across a line of ablation has been one of the main tools
used to evaluate the success of ablations in the electrophys-
iology suite and has recently been proposed as a method tordiovascular Surgery c Volume 144, Number 4 859
Abbreviations and Acronyms
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RF ¼ radiofrequency
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the operating room.7,8 This study tested the efficacy of this
technique to predict chronic conduction block in a porcine
model.MATERIALS AND METHODS
Seven Hanford miniature swine weighing 50 to 70 kg were used in this
study. All animals received humane care in compliance with the Guide for
the Care and Use of Laboratory Animals (National Academy Press, Wash-
ington, DC). Each animal was premedicated with tiletamine HCl (Telazol;
Fort Dodge Animal Health, New York, NY), ketamine, and xylazine; intu-
bated; anesthetized with isoflurane; and monitored continuously through-
out the procedure with electrocardiography and invasive arterial pressure
recordings. Perioperative antibiotics were given during the initial surgery
and consisted of ceftiofur (2 mg/kg). Antibiotics were continued for 3
days postoperatively.
Each pig had a set of right and left atrial ablations performed through
a median sternotomy. After creation of a pericardial sling, a set of 3 molded
silicone plaqueswith a total of 252 unipolar electrodes were placed onto the
epicardial surface to obtain epicardial activation maps. The electrode tem-
plates were constructed from a form-fitting silicon elastomer (Specialty
Silicone Fabricators, Paso Robles, Calif) that fit snugly on the entire atrial
epicardium and contained 0.5-mm diameter silver electrodes (Pacific Wire
& Cable, Inc, Santa Ana, Calif). The interelectrode distance was 5 mm.
These plaques were secured with Rommel tourniquets to allow for consis-
tent placement before and after the lesion set creation. After a baseline ac-
tivated clotting time was measured, a heparin bolus (100 units/kg) was
given intravenously and activated clotting time was maintained at more
than 350 seconds until after all ablations were completed.
Pacing thresholds were obtained on either side of the planned lines of
ablation as shown in Figure 1. Activation maps during normal sinus rhythm
and paced activation (twice threshold, 120 beats/min) were recorded from
identical sites before and immediately after completion of the lesion set.
The lesion set is shown in Figure 1. The atrial appendages were isolated
with a single application of the AtriCure Synergy device, a bipolar RF
clamp device with dual electrodes on each jaw of the clamp. The device
was used per the manufacturer’s instructions. Ablations around the inferior
vena cava and the left pulmonary veins were also created with single appli-
cations of the Synergy device. On the right atrium, a line of ablation was
created with multiple applications of the AtriCure Coolrail device to con-
nect the ablation at the base of the right atrial appendage to the ablation
around the inferior vena cava. This epicardial RF ablation device has
been described in another publication from our laboratory (Figure 2).9
Briefly, the device is a handheld pen-like device that has 2 hollow, 3-cm
long electrodes through which sterile water is circulated during ablation
to reduce tissue-electrode temperature. An analogous line on the left atrium
was created with multiple applications of the Coolrail device between the
base of the left atrial appendage and the left pulmonary veins. Initially, ap-
plication of the Coolrail was planned for 50 seconds with an overlap of 0.5
cm per application based on dosimetry data previously published.9 After
perforation and subsequent death due to intraoperative hemorrhage in the
first pig with this ablation time, the protocol was changed to a 40-second
ablation with only minimal overlap of prior ablation lines.
After completion of the ablation protocol and acquisition of the acute
postablation activation maps, hemostasis was secured. The pericardium860 The Journal of Thoracic and Cardiovascular Surgwas closed, and the sternum was reapproximated. After the operation,
the animal was closely monitored for at least 48 hours and survived for
28 days. Each animal received 325mg of aspirin daily beginning on the first
postoperative day. The animals received buprenorphine (0.005–0.01 mg/kg
intramuscularly) for postoperative analgesia.
At 28 days, the animals underwent a reoperative sternotomy using the
same anesthesia protocol used for the initial operation. The pericardium
was reopened, and the atria were carefully dissected free of adhesions.
The epicardial electrode plaques were repositioned, and activation maps
were obtained during normal sinus rhythm and paced rhythm from the
same sites as during the initial operation.
Once the chronic postablationmaps were obtained, the animals were eu-
thanized humanely with a concentrated potassium chloride solution. The
aorta was crossclamped, and the hearts were perfused with 60 mL of 1%
2,3,5-triphenyl-tetrazolium chloride solution through the coronary circula-
tion via infusion into the root of the aorta. The hearts were removed en bloc
and examined grossly for any evidence of intra-atrial thrombus formation.
They were then placed in 1% 2,3,5-triphenyl-tetrazolium chloride solution
and incubated at room temperature for 45 minutes to aid in visualization of
the ablations. Each lesion was sectioned at 5-mm intervals perpendicular to
the long axis of the ablation. The sections were fixed in formalin, molded in
paraffin, and stained with Gomori trichrome. The sections were microscop-
ically examined to assess transmurality andmeasure lesion depth and tissue
thickness.
Analysis of mapping data was done offline using custom-designed soft-
ware as described previously.10 Unipolar electrogram data were recorded at
a gain of 250 and a frequency response of 0.5 to 500 Hz. The data were dig-
itized at 1000 Hz. Activation times were picked automatically by selecting
the peak derivative of voltage over time from the electrogram after paced
activation. Automatic activation time was manually reviewed and edited
for accuracy. Only the activation maps on the right side of the atria were
analyzed because the left atrium in the Hanford miniature swine was too
narrow in relation to the Coolrail ablation line, and the spatial resolution
of the mapping system was not fine enough to map over the remaining vi-
able tissue of the left atrium.
Statistical Analysis
All data are expressed as mean  standard deviation. Comparison of
conduction time across the line of ablation was done with a Student t test.
RESULTS
Operative Results
The first animal died intraoperatively during the initial
procedure from a perforation caused by the Coolrail device.
In the initial protocol, applications of the device were for 50
seconds, and there was at least 0.5 cm of overlap between
applications to ensure a continuous linear ablation. Given
the perforation, the protocol was modified as noted in the
previous section, and subsequently, the remaining 6 animals
survived the operation. There were no further perforations
caused by the device after adaptation of the new protocol.
There were no postoperative complications related to abla-
tion. None of the animals showed any signs of cerebrovas-
cular accidents or other signs of thromboembolic events.
Histology
Gross visual inspection of ablations revealed no intra-
atrial thrombi. The device performance for the Coolrail is
summarized in Figure 3. Sectioning of the 12 connecting le-
sions created by the Coolrail yielded 72 total cross-sections.ery c October 2012
FIGURE 1. Lesion set used in the study. *Sites of pacing, placed to initiate activation on either side of the planned AtriCure Coolrail (AtriCure Inc, West
Chester, Ohio) device line of ablation (dotted line). IVC, Inferior vena cava.
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connecting lesions created in the study had transmural abla-
tions at every cross-section examined. This was one of the
lines connecting the base of the right atrial appendage to
the inferior vena cava. At least 1 (range, 1–4) cross-
section in each of the other 11 lines demonstrated failure
to achieve transmural ablation. In 2 cases, there was an out-
right gap in the ablation line at the point of overlap between
applications of the Coolrail device. These gaps were ex-
cluded from analysis because they represented tissue that
was not ablated, rather than failed device performance.FIGURE 2. The AtriCure Coolrail device. The 2 electrodes are hollow,
and sterile water is circulated internally to provide cooling of the elec-
trode–tissue interface during ablation. They are 3 mm wide and 30 mm
long.
The Journal of Thoracic and CaDevice performance varied with tissue depth (Figure 3).
In tissue less than 4 mm thick, 97% (33/34) of all cross-
sections examined were transmurally ablated. In tissue 4
mm thick or greater, 58% (22/38) of cross-sections were
transmurally ablated. Average lesion depth for the study
was 3.7  1.5 mm, and tissue thickness was 4.4  2.2
mm. Average lesion width was 8.6  2.5 mm.
Electrophysiology
Complete mapping data, including preablation, acute
postablation, and chronic postablation activation maps,
were available for analysis in 5 animals. The pericardium
of the sixth animal was too tightly adhered to the atrial epi-
cardium to allow for safe dissection and subsequent
mapping.0.0 
2.0 
4.0 
6.0 
8.0 
10.0 
12.0 
0.0 2.0 4.0 6.0 8.0 10.0 12.0 
L
e
s
i
o
n
 
D
e
p
t
h
 
(
m
m
)
 
Tissue Thickness (mm) 
Coolrail Lesion Depth vs. Tissue Thickness 
FIGURE 3. Lesion depth is plotted against tissue thickness. Transmural
ablations lie along the line of identity where lesion depth is equal to tissue
thickness. Dots that fall off this line represent ablations that failed to
achieve transmurality.
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FIGURE 4. Representative sequence of activation maps demonstrating normal paced activation preablation, acute conduction block with a change in ac-
tivation sequence around the ablation line (dotted line) acutely, and recovery of conduction through nontransmural gaps chronically (4 weeks). Conduction
times were measured between the 2 points marked by asterisks.
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FIGURE 5. Conduction time across the Coolrail lesion line (see Figure 4)
is plotted for the preablation, acute postablation, and chronic postablation
periods. There was no statistical difference between conduction times
preablation and chronic postablation 4 weeks after the initial operation
(P ¼ .242).
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vation sequence was used to evaluate for conduction block
on acute and chronic maps (Figure 4). Conduction block
was defined by a change in the activation sequence around
the observed line of block, and conduction delay was de-
fined as delay in conduction without a change in the se-
quence of activation. Four of five activation maps
demonstrated acute conduction block after the ablation
line was performed. The other showed only conduction
delay without block (from 13 ms preablation to 38 ms
postablation) through the line of ablation. Of note, this
map correlated with the sole line of ablation with com-
pletely transmural cross-sections in histologic analysis.
Conduction time in the chronic setting for this right atrium
decreased to 28 ms.
Conduction time across the Coolrail line of ablation was
significantly increased after ablation in the initial operation.
Conduction time before ablation averaged 14.4  5.6 ms.
This increased significantly to 36.8  15.1 ms acutely
postablation (P ¼ .007). Four weeks after ablation, epicar-
dial mapping demonstrated a return to baseline conduction
times. The chronic postablation conduction time averaged
19.4  6.8 ms and was not statistically different from pre-
ablation values (P¼ .242). The conduction time for all 5 an-
imals with complete maps is plotted in Figure 5. In each862 The Journal of Thoracic and Cardiovascular Surgcase, conduction delay across the Coolrail line was in-
creased in the acute postablation map but decreased toward
preablation values in the chronic epicardial map at 4 weeks.DISCUSSION
In the last decade, the Cox-Maze procedure has been
modified to make it more accessible and less invasive. De-
vices have been used to replace the incisions of theery c October 2012
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faster to perform. At Barnes-Jewish Hospital, the use of bi-
polar RF clamps has decreased the operative time by more
than half.3 Moreover, these bipolar devices have been
shown experimentally to create reliable transmural le-
sions.11,12 The bipolar RF-based Cox-Maze IV had
achieved more than 80% freedom from AF off antiarrhyth-
mic drugs at 6 months.13 However, these devices still re-
quire cardiopulmonary bypass and small incisions in the
atria to perform the entire Cox-Maze lesion set.
Less-extensive lesion sets have been introduced to de-
crease the invasiveness of these procedures so they can be
performed without cardiopulmonary bypass. The most
common are limited to pulmonary vein isolation alone
and occasionally involve surgical ablation of the ganglion-
ated plexi.14,15 These operations are attractive because they
can be done with minimal access techniques and without
cardiopulmonary bypass, avoiding potential morbidity.
The results of these new procedures have been less than
satisfactory, particularly in patients with long-standing, per-
sistent AF, in whom the success rates can be less than
50%.14 This is not surprising, and similar results have
been demonstrated in the electrophysiology laboratory
with pulmonary vein isolation alone in patients with long-
standing persistent AF.16
To improve results, more extensive left atrial lesion sets
have been proposed.17 These have required creating linear
lesions on the beating heart. To answer this need, devices
have been recently introduced to perform epicardial beating
heart ablation on the atria.6 However, experience in our lab-
oratory and others has shown that it is difficult to perform
consistently transmural lesions on the beating heart.9,18
We have shown that even small gaps (<1 mm) in a linear
lesion can result in a lack of conduction block.19 Therefore,
it is vital that any new device be tested experimentally be-
fore widespread clinical use. The AtriCure Coolrail device
was introduced specifically to make linear lesions on the
beating heart. The device was not independently tested ex-
perimentally before clinical use. The first goal of this study
was to examine whether the device was capable of creating
consistent transmural ablation in a chronic animal model.
This study simulated the proposed clinical use of the device
by making connecting lesions to create lines of conduction
block.
The Coolrail was not capable of creating a long linear le-
sion in this chronic study. The performance of the Coolrail
has been described by this laboratory in an acute animal
study.9 None of the 12 lines created with the device created
a pathologically or electrically transmural lesion. The only
ablation line that had all histologic sections transmural had
no evidence of conduction block by epicardial mapping. Al-
though every cross-section examined in the line of ablation
was transmural, the pattern of conduction in the chronic ac-
tivation map did not demonstrate acute conduction block,The Journal of Thoracic and Caindicating that there must have been a gap or gaps along
the ablation line.
These chronic results confirm the acute results found af-
ter staining with 1% 2,3,5-triphenyl-tetrazolium chloride
solution. Although this study was not designed specifically
to compare acute histology with chronic histology, compar-
ing the chronic histologic data with previously acquired
acute data, there was no statistically significant difference
in depth of tissue penetration (P ¼ .147) or likelihood of
transmural ablation (P ¼ .621) as determined by acute
staining with 1% 2,3,5-triphenyl-tetrazolium chloride solu-
tion in our prior study9 versus chronic histologic evaluation
with trichrome staining.
The inability of this device and other unidirectional
devices we have tested to create reliably transmural le-
sions emphasizes the importance of developing an intra-
operative method to test for lesion integrity.6 Various
groups have proposed using conduction block or delay as
a way to verify lesion transmurality.7,8 This study also
demonstrated that acute conduction delay or block did
not predict chronic transmurality when used to assess
epicardial RF ablation in the porcine atria. Histologic
analysis demonstrated that the majority of lines created
in this study with the Coolrail contained at least 1 non-
transmural gap. These gaps were not readily identifiable
on the basis of activation sequence mapping. In each
case where a gap was seen clearly in histology, the activa-
tion map demonstrated a pattern consistent with acute con-
duction block. The wavefront of electrical activation
traveled from the right atrial free wall around the anterior
surface of the atrium to activate the atrial tissue on the
opposite side of the line of ablation (Figure 4, acute
postablation). Figure 5 demonstrates that this significantly
increased the conduction time between the 2 selected sites.
In the chronic setting, however, conduction through non-
transmural gaps was clearly identified, and conduction
times returned to baseline (Figures 4 and 5).
A shortcoming of acute intraoperative activation map-
ping is demonstrated in this study. When gaps were pres-
ent histologically, no evidence of this was found acutely
with activation mapping. The phenomenon of chronic re-
covery of conduction is well described in the electrophys-
iology literature. Catheter-based pulmonary vein isolation
for AF is based on identifying and ablating conduction
gaps until the pulmonary veins demonstrate entrance
and exit block.16 Although every effort is made at the ini-
tial ablation to isolate the pulmonary veins, patients can
present with recurrent AF, and repeat electrophysiologic
mapping often reveals recovery of conduction from the
majority of pulmonary vines.20-22 This recovery seen
clinically is similar to the recovery of conduction in this
study. There is evidence of acute injury and recovery at
the tissue level. One echocardiography-based study found
swelling in the ablated crista terminalis that resolved overrdiovascular Surgery c Volume 144, Number 4 863
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the acute conduction block, because localized tissue
swelling and inflammation may lead to acute stunning
and electrical block. However, as the tissue recovered,
electrical activity was restored. Further evidence in the
electrophysiology literature suggests that this recovery
of activation may not take an extended period of time. Ob-
serving the results of pulmonary vein isolation over the
course of an hour revealed recovery of conduction in a sig-
nificant number of patients.24
This study underscores the importance of using a reliable,
rigorously investigated energy source when performing sur-
gical ablation until a reliable method of intraoperative
lesion evaluation is developed. The practice at Barnes-
Jewish Hospital is to use devices that have been shown to
reliably create transmural ablation, such as bipolar RF
clamps.11 In addition, exit block from the pulmonary veins
is confirmed by pacing during surgical ablation. Although
this cannot reliably predict long-term conduction block, it
does address failed ablation acutely, and repeat ablations
are performed until exit block is achieved.
The failure of conduction delay as a means to predict
chronic transmurality has important implications for surgi-
cal practice. In catheter-based procedures, failure to achieve
permanent conduction block with ablation can be remedied
by a relatively low morbidity redo procedure. Thus, an im-
perfect method to predict lesion transmurality carries with it
less risk to the patient. When considering surgical ablation,
a redo operation carries a higher morbidity. Lesion forma-
tion needs to be as complete as possible to help patients
avoid the risk of failure. The Coolrail is unreliable in this
regard.Study Limitations
The animal model used in this study may not perfectly
simulate conditions encountered clinically. The average
thickness of atrial tissue encountered in this study was
4.4  2.2 mm. In some areas of the diseased human atrial,
myocardial thickness can exceed 10 mm.23 Transmural ab-
lation in the diseased human atria may be harder to
accomplish.
During the course of the study, 1 animal had a perforation
that led to intraoperative death. This resulted from a longer
ablation in an area of overlap. The study protocol was mod-
ified to a shorter ablation, and ablations were not overlap-
ped. It is important to note that the clinical use of this
device often involves overlapped ablations of long duration.
Thus, caution should be exercised when applying this de-
vice in this manner in patients.CONCLUSIONS
The AtriCure Coolrail failed to reliably create transmural
lesions. Although the Coolrail was able to create acute864 The Journal of Thoracic and Cardiovascular Surgconduction delay, its failure to transmurally ablate the atrial
myocardium left gaps along the length of the lesion, which
resulted in neither chronic conduction block nor delay
across any line of ablation.
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